Pulmonary Vascular Research Institute

Pulmonary hypertension is a fatal cause of heart failure that affects people of all ages, races, and socioeconomic groups. Sadly, while there are more than 250,000 patients with pulmonary hypertension being treated in the Western world, there are more than 35 million affected patients in poor countries with little or no therapy available.

The 4th PVRI AGM and the 3rd PVRI Workshops and Debates in Lisbon 10-14 Jan 2010

 The Pulmonary Vascular Research Institute is a non-profit international academic medical center. Our activities incorporate the traditional triad of research, education, and clinical care, but the research will focus on pulmonary vascular disease and heart failure, and the education and clinical care will be targeted to countries with healthcare disparities.

The PVRI faculty are volunteers with academic careers in pulmonary vascular medicine and related fields. Their expertise will allow them to conduct basic and translational clinical research at a level that no single academic institution could accomplish. They also provide leadership to foster progress in a way that will best serve the academic community and patients, particularly in underserved areas of the world.

The PVRI will address its objectives primarily by the establishment of focused taskforces that will design and conduct projects across the broad spectrum of research, education and clinical care related to pulmonary vascular disease. 

There is nothing that is similar to the PVRI in its vision, mission, academic strengths, and potential to make major changes in the health of people living in underserved areas of the world. We believe we can make a difference that will be meaningful and reach those in need.

The Mission
The Pulmonary Vascular Research Institute is an independent medical research organisation devoted to increasing the awareness and knowledge of pulmonary vascular diseases, and to facilitating advances in the treatment of affected people worldwide